Kenneth Simmen Selected Research

2- (6- ((2- (3- hydroxypropyl)- 5- methylphenylamino)methyl)- 2- (3- morpholin- 4- ylpropylamino)benzoimidazol- 1- ylmethyl)- 6- methylpyridin- 3- ol

1/2015

Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth Simmen Research Topics

Disease

3	Infections 05/2017 - 11/2010
2	Hepatitis C 01/2011 - 03/2010
1	Dengue (Dengue Fever) 11/2017
1	Fibrosis (Cirrhosis) 01/2011

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 11/2017 - 05/2017
2	SimeprevirIBA 01/2011 - 03/2010
1	2- (6- ((2- (3- hydroxypropyl)- 5- methylphenylamino)methyl)- 2- (3- morpholin- 4- ylpropylamino)benzoimidazol- 1- ylmethyl)- 6- methylpyridin- 3- olIBA 01/2015
1	InterferonsIBA 01/2011
1	Ribavirin (Virazole)FDA LinkGeneric 01/2011
1	RNA (Ribonucleic Acid)IBA 03/2010

Therapy/Procedure

2	Therapeutics 05/2017 - 11/2010